# OnCo record bexmarilimab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bexmarilimab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bexmarilimab" ;
  schema:name "Bexmarilimab"@en ;
  schema:alternateName "FP-1305"@en ;
  schema:description "Bexmarilimab is a monoclonal antibody from Faron Pharmaceuticals Ltd, in registered phase 2 trials for acute myeloid leukaemia, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms, myelodysplastic syndromes / neoplasms."@en ;
  schema:url <https://onco.cc/drugs/bexmarilimab/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Bexmarilimab> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/cmml/>, <https://onco.cc/cancers/mds/> ;
  onco:companies <https://onco.cc/companies/faron-pharmaceuticals/> ;
  onco:trials <https://onco.cc/trials/nct05428969/> .